NCT03116594.

Trial name or title	Immunogenicity and safety of two lots of NBP608 compared to Zostavax in healthy adult aged 50 and over
Methods	Phase 2 and 3 Allocation: randomised Intervention model: parallel assignment Blinding: double‐blind (participant, investigator) Primary purpose: prevention
Participants	675 healthy participants aged 50 years and over
Interventions	Low potency of NBP608 LZV (preparation of Oka/SK strain of live attenuated zoster virus) High potency of NBP608 LZV (preparation of Oka/SK strain of live attenuated zoster virus) Zostavax
Outcomes	Immunogenicity and safety of NBP608 LZV compared to Zostavax
Starting date	January 2014
Contact information	Hee‐Jin Cheong PhD, Korea University Guro Hospital
Notes	Completed, but no results posted on ClinicalTrials.gov and no publications identified Sponsor: SK Chemicals Co Ltd